July 15, 2012: Biocon, Mumbai based leader in Biosimilar molecule market has announced its plans to penetrate into emerging markets through regional marketing partners. The company already has a strong partner network across 32 countries. The company earlier this year started their insulin plant in Malaysia and plans to introduce their biosimilar insulin products to the global market leveraging this plant.
